ウイルス不活性化の世界市場レポート 2025年

ウイルス不活性化市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.9％で82億8,000万米ドルに成長します。予測期間の成長は、自律飛行の開発、次世代航空機の設計、持続可能な航空への取り組み、アーバンエアモビリティ（uam）、航空機需要の増加に起因します。予測期間の世界の動向には、先進アビオニクスの統合、人工知能の実装、ヒューマン・マシン・インターフェース（hmi）の革新、既存航空機の改造、全地球航法衛星システム（gnss）の統合などが含まれます。

さまざまな感染症の罹患率の上昇が、今後数年間のウイルス不活性化市場の成長を促進すると予想されます。感染症とは、ウイルス、細菌、真菌、寄生虫などの病原体だけでなく、汚染された飲食品を介して個人から個人へ感染する可能性のある状態を指します。ウイルス不活性化は、物理的・化学的な消毒剤を用いてウイルスを不活性化することで、伝染性のウイルス感染症の蔓延を防ぎ、ウイルス不活性化市場の拡大に貢献するなど、ヒトの疾病管理プログラムにおいて重要な役割を果たしています。例えば、2024年3月に米国の国立公衆衛生機関である疾病対策予防センター（CDC）が発表した結核患者数は、2022年の8,320人から2023年には9,615人と1,295人増加しました。罹患率も2022年の10万人当たり2.5人から2023年には2.9人に上昇しました。このように、さまざまな感染症の有病率の増加がウイルス不活性化市場の成長を促進しています。

がん患者の急増がウイルス不活性化市場の成長を促進します。がんは、腫瘍形成につながる異常細胞の無秩序な増殖と拡散を特徴とし、生物学的製品を含む治療が必要となります。ウイルス不活性化を通じてこれらの製品の安全性を確保することは、がん治療を受ける患者の潜在的な感染症を予防する上で最も重要になります。米国を拠点とする非営利医療団体である米国がん協会によると、米国における新規がん患者数は2022年の1,918,030人以上から2023年には1,958,310人に増加すると予測されています。このようながん患者の増加は、市場におけるウイルス不活性化の重要性の高まりを裏付けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ウイルス不活性化PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のウイルス不活性化市場：成長率分析
• 世界のウイルス不活性化市場の実績：規模と成長, 2019-2024
• 世界のウイルス不活性化市場の予測：規模と成長, 2024-2029, 2034F
• 世界ウイルス不活性化総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のウイルス不活性化市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キットと試薬
• システム
• サービス
• 世界のウイルス不活性化市場：方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 溶剤洗剤法
• pH調整方法
• 殺菌
• その他の方法
• 世界のウイルス不活性化市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチンと治療薬
• ティッシュおよびティッシュ製品
• 血液および血液製品
• その他の用途
• 世界のウイルス不活性化市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 契約調査機関
• 血液銀行
• 病院
• 学術調査機関
• その他のエンドユーザー
• 世界のウイルス不活性化市場、キットと試薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウイルス不活性化キット
• PCR試薬
• 抗体と酵素
• 世界のウイルス不活性化市場、システムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動化されたウイルス不活性化システム
• バッチウイルス不活性化システム
• 連続フローシステム
• 世界のウイルス不活性化市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウイルス検査サービス
• 検証サービス
• コンサルティングサービス

第7章 地域別・国別分析

• 世界のウイルス不活性化市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のウイルス不活性化市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ウイルス不活性化市場：競合情勢
• ウイルス不活性化市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • Texcell SA Overview, Products and Services, Strategy and Financial Analysis
  • SGS SA Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Clean Cells SAS
• Rad Source Technologies
• WuXi AppTec
• Sigma-Aldrich Co. LLC
• Thermo Fisher Scientific Inc.
• Macopharma
• Cerus Corporation
• TERUMO BCT INC.
• Shandong Weigao Group Medical Polymer Co. Ltd.
• Pall Corporation
• Eurofins Scientific
• General Electric Company
• Cytiva
• Mettler Toledo
• Viral Inactivated Plasma Systems SA

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ウイルス不活性化市場2029：新たな機会を提供する国
• ウイルス不活性化市場2029：新たな機会を提供するセグメント
• ウイルス不活性化市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Viral inactivation is the process of neutralizing viral contamination by exposing the bioprocess fluid to environments that denature viral proteins while preserving the active ingredient of the product. This method finds common application in blood plasma processing and monoclonal antibody processing.

The primary outcomes of viral inactivation are kits and reagents, systems, and services. The solvent detergent method is a technique that damages the lipid membrane of encapsulated viruses, leading to their inactivation. This method is frequently employed in plasma processing to safely deactivate all lipid-enveloped viruses. Viral inactivation encompasses various methods, including the solvent detergent method, pH adjustment method, pasteurization, and others. These methods are applied in vaccines and therapeutics, tissues and tissue products, blood and blood products, and various other applications. End-users of viral inactivation include pharmaceutical and biotechnology companies, contract research organizations, blood banks, hospitals, academic research institutes, and other entities.

The viral inactivation market research report is one of a series of new reports from The Business Research Company that provides viral inactivation market statistics, including viral inactivation industry global market size, regional shares, competitors with a viral inactivation market share, detailed viral inactivation market segments, market trends and opportunities, and any further data you may need to thrive in the viral inactivation industry. This viral inactivation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viral inactivation market size has grown strongly in recent years. It will grow from$5.01 billion in 2024 to $5.48 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to global air traffic growth, enhanced navigation capabilities, commercial aviation expansion, airline cost savings, improved flight safety, reduction in pilot workload

The viral inactivation market size is expected to see rapid growth in the next few years. It will grow to $8.28 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to autonomous flight development, next-generation aircraft designs, efforts for sustainable aviation, urban air mobility (uam), increasing demand for aircraft. Major trends in the forecast period include integration of advanced avionics, implementation of artificial intelligence, human-machine interface (hmi) innovations, retrofitting existing aircraft, global navigation satellite system (gnss) integration.

The rising incidence of various infectious diseases is expected to drive the growth of the viral inactivation market in the coming years. Infectious diseases are conditions that can be transmitted from one individual to another through contaminated food and beverages, as well as via pathogens such as viruses, bacteria, fungi, and parasites. Viral inactivation plays a crucial role in human disease-control programs by using physical and chemical disinfectants to inactivate viruses, thereby preventing the spread of contagious viral infections and contributing to the expansion of the viral inactivation market. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. The incidence rate also rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Thus, the increasing prevalence of various infectious diseases is fueling the growth of the viral inactivation market.

The surge in the prevalence of cancer cases is poised to drive the growth of the viral inactivation market. Cancer, characterized by the uncontrolled growth and spread of abnormal cells leading to tumor formation, necessitates treatments involving biological products. Ensuring the safety of these products through viral inactivation becomes paramount in preventing potential infections among patients undergoing cancer treatments. According to the American Cancer Society Inc., a US-based non-profit health group, the projected number of new cancer cases in the US is expected to increase from over 1,918,030 in 2022 to 1,958,310 in 2023. This escalation in cancer cases underscores the growing importance of viral inactivation in the market.

A prominent trend gaining traction in the viral inactivation market is the increased adoption of technologically advanced processes. Companies within this market are incorporating state-of-the-art technologies to maintain their competitive positions. For example, in March 2022, WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, a China-based biopharmaceutical company, introduced the Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This cutting-edge approach facilitates the approval of new therapies by concurrently conducting all assay formulation, biosafety, viral clearance, product release, and testing in-house. TESSA Technology represents an innovative method for producing adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) grade without the need for transfection.

Major players in the viral inactivation market are focusing on the development of groundbreaking products, such as non-hazardous viral inactivation mediums, to gain a competitive edge. Non-hazardous viral inactivation mediums are formulations designed to inactivate viruses in laboratory or clinical settings without posing risks or hazards to individuals handling the samples. Thermo Fisher Scientific Inc., a US-based biotechnology company, exemplified this approach in March 2022 with the launch of the InhibiSURE Viral Inactivation Medium. This breakthrough formulation is specifically designed for the safe collection and transport of the SARS-CoV-2 virus, ensuring rapid inactivation and stabilization of viral RNA at ambient temperature. The medium eliminates potential hazards associated with traditional inactivation media, enhancing laboratory safety and contributing to a secure and efficient sample collection and transport process.

In June 2022, Asahi Kasei Medical, a Japan-based healthcare company specializing in chemical manufacturing, acquired Bionova Scientific for an undisclosed amount. This acquisition provides Asahi Kasei access to Bionova's 36,000-square-foot production facility equipped with two 2,000-litre mammalian cell culture trains. The facility has the capacity to produce various monoclonal antibodies and other recombinant proteins. Post-acquisition, Asahi Kasei aims to leverage its existing businesses in bioprocess supplies, tools, biosafety testing services, and the biologics CDMO division of Bionova Scientific. Bionova Scientific, a US-based company, is engaged in the cGMP manufacturing of biologics and downstream purification processes for viral inactivation and viral filtration.

Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited

North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the viral inactivation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The viral inactivation market includes revenues earned by chemical viral inactivation and radiation viral inactivation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Inactivation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral inactivation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral inactivation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The viral inactivation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Kits And Reagents; Systems; Services
• 2) By Method: Solvent Detergent Method; pH Adjustment Method; Pasteurization; Other Methods
• 3) By Application: Vaccines And Therapeutics; Tissues And Tissue Products; Blood And Blood Products; Other Applications
• 4) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Blood Banks; Hospital; Academic Research Institutes; Other End Users
• Subsegments:
• 1) By Kits And Reagents: Viral Inactivation Kits; PCR Reagents; Antibodies and Enzymes
• 2) By Systems: Automated Viral Inactivation Systems; Batch Viral Inactivation Systems; Continuous Flow Systems
• 3) By Services: Viral Testing Services; Validation Services; Consulting Services
• Companies Mentioned: Merck & Co. Inc.; Sartorius AG; Texcell SA; SGS SA; Charles River Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viral Inactivation Market Characteristics

3. Viral Inactivation Market Trends And Strategies

4. Viral Inactivation Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Viral Inactivation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Viral Inactivation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Viral Inactivation Market Growth Rate Analysis
• 5.4. Global Viral Inactivation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Viral Inactivation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Viral Inactivation Total Addressable Market (TAM)

6. Viral Inactivation Market Segmentation

• 6.1. Global Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits And Reagents
• Systems
• Services
• 6.2. Global Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solvent Detergent Method
• pH Adjustment Method
• Pasteurization
• Other Methods
• 6.3. Global Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines And Therapeutics
• Tissues And Tissue Products
• Blood And Blood Products
• Other Applications
• 6.4. Global Viral Inactivation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations
• Blood Banks
• Hospital
• Academic Research Institutes
• Other End Users
• 6.5. Global Viral Inactivation Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Inactivation Kits
• PCR Reagents
• Antibodies and Enzymes
• 6.6. Global Viral Inactivation Market, Sub-Segmentation Of Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Viral Inactivation Systems
• Batch Viral Inactivation Systems
• Continuous Flow Systems
• 6.7. Global Viral Inactivation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Testing Services
• Validation Services
• Consulting Services

7. Viral Inactivation Market Regional And Country Analysis

• 7.1. Global Viral Inactivation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Viral Inactivation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Inactivation Market

• 8.1. Asia-Pacific Viral Inactivation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Inactivation Market

• 9.1. China Viral Inactivation Market Overview
• 9.2. China Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Inactivation Market

• 10.1. India Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Inactivation Market

• 11.1. Japan Viral Inactivation Market Overview
• 11.2. Japan Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Inactivation Market

• 12.1. Australia Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Inactivation Market

• 13.1. Indonesia Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Inactivation Market

• 14.1. South Korea Viral Inactivation Market Overview
• 14.2. South Korea Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Inactivation Market

• 15.1. Western Europe Viral Inactivation Market Overview
• 15.2. Western Europe Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Inactivation Market

• 16.1. UK Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Inactivation Market

• 17.1. Germany Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Inactivation Market

• 18.1. France Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Inactivation Market

• 19.1. Italy Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Inactivation Market

• 20.1. Spain Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Inactivation Market

• 21.1. Eastern Europe Viral Inactivation Market Overview
• 21.2. Eastern Europe Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Inactivation Market

• 22.1. Russia Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Inactivation Market

• 23.1. North America Viral Inactivation Market Overview
• 23.2. North America Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Inactivation Market

• 24.1. USA Viral Inactivation Market Overview
• 24.2. USA Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Inactivation Market

• 25.1. Canada Viral Inactivation Market Overview
• 25.2. Canada Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Inactivation Market

• 26.1. South America Viral Inactivation Market Overview
• 26.2. South America Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Inactivation Market

• 27.1. Brazil Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Inactivation Market

• 28.1. Middle East Viral Inactivation Market Overview
• 28.2. Middle East Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Inactivation Market

• 29.1. Africa Viral Inactivation Market Overview
• 29.2. Africa Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Inactivation Market Competitive Landscape And Company Profiles

• 30.1. Viral Inactivation Market Competitive Landscape
• 30.2. Viral Inactivation Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Texcell SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. SGS SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Viral Inactivation Market Other Major And Innovative Companies

• 31.1. Clean Cells SAS
• 31.2. Rad Source Technologies
• 31.3. WuXi AppTec
• 31.4. Sigma-Aldrich Co. LLC
• 31.5. Thermo Fisher Scientific Inc.
• 31.6. Macopharma
• 31.7. Cerus Corporation
• 31.8. TERUMO BCT INC.
• 31.9. Shandong Weigao Group Medical Polymer Co. Ltd.
• 31.10. Pall Corporation
• 31.11. Eurofins Scientific
• 31.12. General Electric Company
• 31.13. Cytiva
• 31.14. Mettler Toledo
• 31.15. Viral Inactivated Plasma Systems SA

32. Global Viral Inactivation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Inactivation Market

34. Recent Developments In The Viral Inactivation Market

35. Viral Inactivation Market High Potential Countries, Segments and Strategies

• 35.1 Viral Inactivation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Viral Inactivation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Viral Inactivation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer